SCHEMBL3498534

SCHEMBL3498534

c1ccc(Cc2c[nH]c(-c3ccsc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2E1 P05181 1/20 0.41
CYP2A6 P11509 1/20 0.41
CYP2B6 P20813 1/20 0.41
CDK8 P49336 1/20 0.39
CYP17A1 P05093 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
KDM4E B2RXH2 1/20 0.37
TSHR P16473 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
PRMT6 Q96LA8 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RET P07949 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9369368 0.85 PNP (0.37) CYP2E1CYP2A6CYP2B6CDK8ALDH1A1
SCHEMBL17622 0.82 CXCR2 (0.42) KDM4EHSD17B10ALDH1A1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL8588873 0.81 CXCR2 (0.41) KDM4EHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL17279789 0.78 SMN1; SMN2 (0.42) KDM4EHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL7010798 0.76 TAAR1 (0.41) CYP2E1CYP2A6CYP2B6CDK8PDGFRB
SCHEMBL7487640 0.76 NPC1 (0.43) CYP17A1CYP11B1CYP11B2KDM4EHSD17B10
SCHEMBL14059820 0.75 CYP2A6 (0.50) CYP2E1CYP2A6CYP2B6CDK8PDGFRB
SCHEMBL7100910 0.73 GSK3B (0.41) CYP2E1CYP2A6CYP2B6CDK8CYP17A1
SCHEMBL8973626 0.73 GABRA1 (0.55) KDM4EHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL28783020 0.73 TAAR1 (0.47) CYP2A6CDK8KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168443-A1 Ethoid-Containing Compounds, Methods for Preparing Ethoid-Containing Compounds, and Methods of Use UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168443-A1 Ethoid-Containing Compounds, Methods for Preparing Ethoid-Containing Compounds, and Methods of Use PARG, POLH, PHOSPHO1 CYP2E1 1058/4885CYP2A6 1457/4885CYP2B6 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.